×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Apexigen Inc. (APGN) NASDAQ

$0.39 - (-)

Market Cap: -

As of 08/22/23 12:00 AM EDT. Market closed.

(APGN)

Apexigen Inc. (APGN)
NASDAQ

$0.39
- (-)

Market Cap: -

As of 08/22/23 12:00 AM EDT. Market closed.

Add to Portfolio

apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by apximab™, the company’s proprietary antibody drug discovery platform. its lead immuno-oncology drug candidate, apx005m, is a potent immune-activating antibody against cd40 currently in phase 2 clinical ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
PRICE CHART FOR APEXIGEN INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.38
Previous Close
$0.39
Days Range
$0.36 - $0.40
52 week range
- - -
Volume
95,726
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
24,861,926
Open
$0.38
Previous Close
$0.39
Days Range
$0.36 - $0.40
52 week range
- - -
Volume
95,726
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
24,861,926
FINANCIAL STATEMENTS FOR APEXIGEN INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APEXIGEN INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Wong AmySVP, Finance and OperationsAug 23, 2023 Option Exercise$0.3915,5615,99366,565Aug 25, 2023, 07:20 PM
Sarena Francis WillardPresident and COOAug 23, 2023 Option Exercise$0.3931,12311,985124,296Aug 25, 2023, 07:17 PM
Duke William E.Chief Financial OfficerAug 23, 2023 Option Exercise$0.3926,41610,173128,001Aug 25, 2023, 06:42 PM
Yang XiaodongChief Executive OfficerAug 23, 2023 Option Exercise$0.3969,16126,634863,729Aug 25, 2023, 06:37 PM
Yang XiaodongChief Executive OfficerJun 15, 2023 Option Exercise$0.497,0013,438532,890Jun 23, 2023, 06:01 PM
Wong AmySVP, Finance and OperationsJun 15, 2023 Option Exercise$0.492,7771,36482,126Jun 23, 2023, 05:57 PM
Sarena Francis WillardPresident and COOJun 15, 2023 Option Exercise$0.496,9173,397155,419Jun 23, 2023, 05:54 PM
Hsu Frank J.Chief Medical OfficerJun 15, 2023 Option Exercise$0.494,3232,12316,354Jun 23, 2023, 05:51 PM
Duke William E.Chief Financial OfficerJun 15, 2023 Option Exercise$0.494,5042,212154,417Jun 23, 2023, 05:49 PM
Wong AmySVP, Finance and OperationsMay 23, 2023 Option Exercise$0.4012,2344,89484,903May 25, 2023, 04:25 PM
Duke William E.Chief Financial OfficerMay 23, 2023 Option Exercise$0.4017,2616,904158,921May 25, 2023, 04:21 PM
Sarena Francis WillardPresident and COOMay 23, 2023 Option Exercise$0.4020,7488,299162,336May 25, 2023, 04:18 PM
Wong AmySVP, Finance and OperationsDec 15, 2022 Option Exercise$1.062,8513,02213,637Dec 19, 2022, 05:57 PM
Sarena Francis WillardChief Operating OfficerDec 15, 2022 Option Exercise$1.066,9167,33133,084Dec 19, 2022, 05:49 PM
Hsu Frank J.Chief Medical OfficerDec 15, 2022 Option Exercise$1.064,3234,58220,677Dec 19, 2022, 05:41 PM
Duke William E.Chief Financial OfficerDec 15, 2022 Option Exercise$1.064,5034,77326,182Dec 19, 2022, 05:09 PM
Yang XiaodongChief Executive OfficerDec 15, 2022 Option Exercise$1.067,0017,421531,391Dec 19, 2022, 05:00 PM
GLAZER CAPITAL, LLC10% OwnerFeb 11, 2021 Sale$11.31400,0004,524,000225,000Feb 16, 2021, 04:46 PM
Brookline Capital Holdings LLC10% OwnerFeb 02, 2021 Buy$10.00247,0002,470,0001,627,000Feb 04, 2021, 03:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Wong AmySVP, Finance and Operations08/23/20235,993
Sarena Francis WillardPresident and COO08/23/202311,985
Duke William E.Chief Financial Officer08/23/202310,173
Yang XiaodongChief Executive Officer08/23/202326,634
Yang XiaodongChief Executive Officer06/15/20233,438
Wong AmySVP, Finance and Operations06/15/20231,364
Sarena Francis WillardPresident and COO06/15/20233,397
Hsu Frank J.Chief Medical Officer06/15/20232,123
Duke William E.Chief Financial Officer06/15/20232,212
Wong AmySVP, Finance and Operations05/23/20234,894
Duke William E.Chief Financial Officer05/23/20236,904
Sarena Francis WillardPresident and COO05/23/20238,299
Wong AmySVP, Finance and Operations12/15/20223,022
Sarena Francis WillardChief Operating Officer12/15/20227,331
Hsu Frank J.Chief Medical Officer12/15/20224,582
Duke William E.Chief Financial Officer12/15/20224,773
Yang XiaodongChief Executive Officer12/15/20227,421
GLAZER CAPITAL, LLC10% Owner02/11/20214,524,000
Brookline Capital Holdings LLC10% Owner02/02/20212,470,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR APEXIGEN INC
STOCK BUYBACKS FOR APEXIGEN INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2023
12/31/2022
7.54%
1Q
03/31/2023
09/30/2022
17.93%
2Q
03/31/2023
06/30/2022
-23.20%
3Q
03/31/2023
03/31/2022
33.58%
4Q
03/31/2023
12/31/2021
33.82%
5Q
03/31/2023
09/30/2021
33.90%
6Q
03/31/2023
06/30/2021
-21.85%
7Q
03/31/2023
03/31/2021
-21.19%
8Q
Load More

Period of Report: 03/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
7.54%
1Q
09/30/2022
17.93%
2Q
06/30/2022
-23.20%
3Q
03/31/2022
33.58%
4Q
12/31/2021
33.82%
5Q
09/30/2021
33.90%
6Q
06/30/2021
-21.85%
7Q
03/31/2021
-21.19%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR APEXIGEN INC
LOADING...